Burosumab-twza Subcutaneous and Insulin glulisine Subcutaneous
Determining the interaction of Burosumab-twza Subcutaneous and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: burosumab
Brand name: Crysvita
Synonyms: Burosumab
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Burosumab-twza Subcutaneous-Insulin human inhaled Inhalation
- Burosumab-twza Subcutaneous-Insulin human regular Injection
- Burosumab-twza Subcutaneous-Insulin inhalation
- Burosumab-twza Subcutaneous-Insulin isophane
- Burosumab-twza Subcutaneous-Insulin isophane and insulin regular
- Burosumab-twza Subcutaneous-Insulin lispro
- Insulin glulisine Subcutaneous-Buspar
- Insulin glulisine Subcutaneous-Buspar Dividose
- Insulin glulisine Subcutaneous-Buspirone
- Insulin glulisine Subcutaneous-Buspirone Hydrochloride
- Insulin glulisine Subcutaneous-Busulfan
- Insulin glulisine Subcutaneous-Busulfan Concentrate Injection